PTC Therapeutics (PTCT) announced that the FDA accelerated approval of its gene therapy for the treatment of AADC deficiency, the first-ever ...
Key events this week, including the US CPI data and the speech by the Federal Reserve Chair, will be critical in providing ...
Joseph Schwartz, an analyst from Leerink Partners, reiterated the Hold rating on PTC Therapeutics (PTCT – Research Report). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback